13FPulse
CR

CRL CHARLES RIVER LABORATORIES

2026Q2 · CUSIP 159864107 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
558
Institutions that reported holding it to the SEC
Net increase in holders
0
Last quarter 558 → now 558
How unusual is that
Below average
Stronger than only 36% of US stocks
What the filings say, in one paragraph

558 funds held CRL at the end of 2026Q2. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $4.0B(YoY -0.7%), return on equity is -8.4%. CRL has had 18 buying rushes in its history, and the price moved +3.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=229 2013Q4: holders=234 2014Q1: holders=257 2014Q2: holders=260 2014Q3: holders=253 2014Q4: holders=252 2015Q1: holders=255 2015Q2: holders=262 2015Q3: holders=255 2015Q4: holders=265 2016Q1: holders=262 2016Q2: holders=284 2016Q3: holders=280 2016Q4: holders=295 2017Q1: holders=301 2017Q2: holders=303 2017Q3: holders=333 2017Q4: holders=336 2018Q1: holders=334 2018Q2: holders=349 2018Q3: holders=363 2018Q4: holders=405 2019Q1: holders=410 2019Q2: holders=402 2019Q3: holders=399 2019Q4: holders=414 2020Q1: holders=413 2020Q2: holders=464 2020Q3: holders=490 2020Q4: holders=538 2021Q1: holders=558 2021Q2: holders=634 2021Q3: holders=679 2021Q4: holders=706 2022Q1: holders=644 2022Q2: holders=625 2022Q3: holders=582 2022Q4: holders=633 2023Q1: holders=622 2023Q2: holders=610 2023Q3: holders=621 2023Q4: holders=637 2024Q1: holders=675 2024Q2: holders=666 2024Q3: holders=629 2024Q4: holders=637 2025Q1: holders=564 2025Q2: holders=519 2025Q3: holders=555 2025Q4: holders=586 2026Q1: holders=558 2026Q2: holders=558 -76 -38 +0 +38 +76 206474742 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 18 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q4 Top 20% -5.0%
2025Q3 Top 10% +0.9% -4.1%
2024Q1 Top 10% -7.9% -15.3%
2023Q3 Top 20% +26.0% +17.7%
2022Q4 Top 10% -21.6% -21.8%
2021Q4 Top 20% -26.3% -27.9%
2021Q3 Top 5% -25.8% -41.0%
2021Q2 Top 1% in the market -5.1% -26.6%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
247
Change in large funds
+16
Total value they hold
$13.3B
Funds buying for the first time
78
Funds that sold out entirely
78
Price change that quarter
+94.6%
Funds holding puts (bearish)
6
Funds holding calls (bullish)
6

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-4.80
EPS YoY
Revenue (TTM)
$4.0B
Revenue YoY
-0.7%
Net margin
-6.0%
ROE
-8.4%
Debt ratio
61.7%
FCF (TTM)
$371M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-25: EPS 2.01 2021-12-25: EPS 2.67 2022-03-26: EPS 1.81 2022-06-25: EPS 2.13 2022-09-24: EPS 1.88 2022-12-31: EPS 3.66 2023-04-01: EPS 2.01 2023-07-01: EPS 1.89 2023-09-30: EPS 1.69 2023-12-30: EPS 3.63 2024-03-30: EPS 1.30 2024-06-29: EPS 1.74 2024-09-28: EPS 1.33 2024-12-28: EPS -4.17 2025-03-29: EPS 0.50 2025-06-28: EPS 1.06 2025-09-27: EPS 1.10 2025-12-27: EPS -5.57 2026-03-28: EPS -0.30 2026-06-27: EPS -0.03 0B 0.5B 1.1B $B -6.13 -1.05 4.03 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 26 18 411 804 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-15M99M213M 20162017201820192020202120222023202420252026
Latest quarter $-15M (2026-03-28)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-27 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.